Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FNKPV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,062
Award facts
- Contract value 100% obligated
- $23,061.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cosentyx (secukinumab) 300 mg pen injections in 2 mL formulations. This firm fixed-price delivery order, valued at $23,061.94, represents a non-competitive set-aside award and is scheduled for completion by September 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's DLA IDC enables the supply of a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs globally, including customers such as the Defense Health Agency and the U.S. Coast Guard. This specific delivery order for Cosentyx, a specialty immunosuppressant medication, exemplifies AmerisourceBergen's role in fulfilling specialized pharmaceutical needs within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FNKPV?
SPE2DB25FNKPV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FNKPV worth?
The government has obligated $23,062 on SPE2DB25FNKPV.
Is contract SPE2DB25FNKPV an order under another contract?
Yes. SPE2DB25FNKPV is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNKPV competed?
The extent of competition for SPE2DB25FNKPV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award